News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,870 Results
Type
Article (40476)
Company Profile (274)
Press Release (667119)
Multimedia
Podcasts (62)
Webinars (14)
Section
Business (205244)
Career Advice (2025)
Deals (35573)
Drug Delivery (97)
Drug Development (81339)
Employer Resources (172)
FDA (16279)
Job Trends (14946)
News (346828)
Policy (32717)
Tag
Academia (2576)
Accelerated approval (9)
Adcomms (22)
Allergies (95)
Alliances (49927)
ALS (108)
Alzheimer's disease (1445)
Antibody-drug conjugate (ADC) (154)
Approvals (16274)
Artificial intelligence (309)
Autoimmune disease (29)
Automation (18)
Bankruptcy (364)
Best Places to Work (11661)
BIOSECURE Act (20)
Biosimilars (122)
Biotechnology (190)
Bladder cancer (94)
Brain cancer (33)
Breast cancer (365)
Cancer (2863)
Cardiovascular disease (211)
Career advice (1694)
Career pathing (30)
CAR-T (188)
CDC (30)
Cell therapy (503)
Cervical cancer (22)
Clinical research (66967)
Collaboration (1023)
Company closure (3)
Compensation (686)
Complete response letters (22)
COVID-19 (2640)
CRISPR (57)
C-suite (324)
Cystic fibrosis (112)
Data (2984)
Decentralized trials (2)
Denatured (23)
Depression (63)
Diabetes (347)
Diagnostics (6447)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (136)
Drug pricing (123)
Drug shortages (28)
Duchenne muscular dystrophy (124)
Earnings (87569)
Editorial (40)
Employer branding (21)
Employer resources (148)
Events (114267)
Executive appointments (853)
FDA (17922)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (937)
Gene editing (131)
Generative AI (22)
Gene therapy (373)
GLP-1 (784)
Government (4513)
Grass and pollen (4)
Guidances (181)
Healthcare (18863)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (151)
Immuno-oncology (8)
Indications (39)
Infectious disease (2813)
Inflammatory bowel disease (151)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (119)
Interviews (312)
IPO (16625)
IRA (46)
Job creations (3672)
Job search strategy (1437)
Kidney cancer (13)
Labor market (52)
Layoffs (498)
Leadership (18)
Legal (7965)
Liver cancer (79)
Lung cancer (399)
Lymphoma (208)
Machine learning (11)
Management (58)
Manufacturing (383)
MASH (90)
Medical device (13468)
Medtech (13473)
Mergers & acquisitions (19660)
Metabolic disorders (847)
Multiple sclerosis (97)
NASH (16)
Neurodegenerative disease (115)
Neuropsychiatric disorders (32)
Neuroscience (2123)
NextGen: Class of 2025 (6555)
Non-profit (4501)
Now hiring (47)
Obesity (425)
Opinion (221)
Ovarian cancer (100)
Pain (106)
Pancreatic cancer (122)
Parkinson's disease (186)
Partnered (22)
Patents (296)
Patient recruitment (160)
Peanut (50)
People (58032)
Pharmaceutical (67)
Pharmacy benefit managers (21)
Phase I (20890)
Phase II (29503)
Phase III (21942)
Pipeline (1623)
Policy (201)
Postmarket research (2564)
Preclinical (8900)
Press Release (64)
Prostate cancer (139)
Psychedelics (36)
Radiopharmaceuticals (253)
Rare diseases (457)
Real estate (5965)
Recruiting (66)
Regulatory (22692)
Reports (50)
Research institute (2335)
Resumes & cover letters (351)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (86)
Series A (161)
Series B (109)
Service/supplier (13)
Sickle cell disease (60)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (32)
Startups (3644)
State (2)
Stomach cancer (14)
Supply chain (75)
Tariffs (57)
The Weekly (37)
Vaccines (782)
Venture capital (55)
Weight loss (256)
Women's health (46)
Worklife (16)
Date
Today (41)
Last 7 days (393)
Last 30 days (1817)
Last 365 days (31329)
2025 (16729)
2024 (35337)
2023 (40181)
2022 (51293)
2021 (55842)
2020 (54157)
2019 (46661)
2018 (35137)
2017 (32231)
2016 (31638)
2015 (37724)
2014 (31462)
2013 (26510)
2012 (28787)
2011 (29434)
2010 (27528)
Location
Africa (724)
Alabama (61)
Alaska (7)
Arizona (243)
Arkansas (13)
Asia (38425)
Australia (6282)
California (7439)
Canada (2352)
China (671)
Colorado (322)
Connecticut (317)
Delaware (192)
Europe (82658)
Florida (1115)
Georgia (247)
Hawaii (1)
Idaho (60)
Illinois (639)
India (27)
Indiana (361)
Iowa (16)
Japan (227)
Kansas (109)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1020)
Massachusetts (5529)
Michigan (245)
Minnesota (449)
Mississippi (3)
Missouri (89)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (67)
New Jersey (2071)
New Mexico (28)
New York (2084)
North Carolina (1078)
North Dakota (8)
Northern California (3271)
Ohio (237)
Oklahoma (16)
Oregon (35)
Pennsylvania (1611)
Puerto Rico (17)
Rhode Island (36)
South America (1102)
South Carolina (34)
South Dakota (1)
Southern California (2781)
Tennessee (125)
Texas (1120)
United States (27554)
Utah (219)
Virginia (184)
Washington D.C. (73)
Washington State (633)
West Virginia (4)
Wisconsin (65)
707,870 Results for "decipher biosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research
May 29, 2025
·
9 min read
Press Releases
Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
April 28, 2025
·
6 min read
Biotech Bay
Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Veracyte, Inc today announced that nine abstracts focused on its Decipher Prostate and Decipher Bladder Genomic Classifiers will be presented at AUA 2024, the annual meeting of the American Urological Association, taking place May 3-6 in San Antonio.
April 16, 2024
·
7 min read
Press Releases
Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants
May 21, 2025
·
1 min read
Press Releases
Forte Biosciences, Inc. Announces Results and Provides Update
May 15, 2025
·
5 min read
Press Releases
Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering
May 29, 2025
·
5 min read
Press Releases
Veracyte Announces Multiple Abstracts Demonstrating Power of Decipher Testing To Fuel New Prostate and Bladder Cancer Insights Will Be Presented at AUA Annual Meeting
April 22, 2025
·
8 min read
Drug Development
Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
Natera, Inc., a global leader in cell-free DNA and genetic testing, announced a new gastroesophageal cancer trial, DECIPHER, that will utilize the company’s personalized and tumor-informed molecular residual disease test, Signatera™, to guide patient selection and assess the rate of MRD clearance in patients being treated for gastroesophageal cancer.
June 27, 2024
·
5 min read
Press Releases
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
April 21, 2025
·
4 min read
Press Releases
Parse Biosciences Partners with Japanese Distributor, SCRUM Inc.
April 2, 2025
·
2 min read
1 of 70,787
Next
